Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

892.20p
   
  • Change Today:
    -5.80p
  • 52 Week High: 2,297.00p
  • 52 Week Low: 855.60p
  • Currency: UK Pounds
  • Shares Issued: 240.68m
  • Volume: 403,157
  • Market Cap: £2,147.34m
  • RiskGrade: 215

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
10-Jan-18 Jefferies Underperform 1,009.00p 1,074.00p 895.00p DownGrade
19-Dec-17 numis Buy 1,120.00p 1,300.00p 1,300.00p Reiteration
24-Aug-17 Citigroup Neutral 1,237.00p - 1,350.00p Reiteration
22-Aug-17 Goldman Sachs Neutral 1,188.00p 2,600.00p 1,310.00p DownGrade
11-Aug-17 Numis Securities Add 1,286.00p - 1,560.00p Reiteration
02-Aug-17 Morgan Stanley Equal-weight 1,413.00p 2,050.00p 1,600.00p DownGrade
03-Jul-17 Barclays Overweight 1,429.00p 2,200.00p 2,200.00p Reiteration
27-Jun-17 HSBC Reduce 1,516.00p 1,700.00p 1,410.00p Reiteration
23-May-17 JP Morgan Cazenove Neutral 1,680.00p 1,800.00p 1,500.00p Reiteration
25-Jan-17 Peel Hunt Limited Buy 1,863.00p - 2,340.00p Reiteration
16-Mar-16 Panmure Gordon Buy 1,815.00p - 2,120.00p Upgrade

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

HIK Market Data

Currency UK Pounds
Share Price 892.20p
Change Today -5.80p
% Change -0.65 %
52 Week High 2,297.00p
52 Week Low 855.60p
Volume 403,157
Shares Issued 240.68m
Market Cap £2,147.34m
RiskGrade 215

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.55% above the market average67.55% above the market average67.55% above the market average67.55% above the market average67.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
88.89% below the market average88.89% below the market average88.89% below the market average88.89% below the market average88.89% below the market average
72.31% below the sector average72.31% below the sector average72.31% below the sector average72.31% below the sector average72.31% below the sector average
Income
5.27% below the market average5.27% below the market average5.27% below the market average5.27% below the market average5.27% below the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Growth
61.71% below the market average61.71% below the market average61.71% below the market average61.71% below the market average61.71% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 7
Sell 0
Strong Sell 2
Total 13
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 24-Aug-17 06-Apr-17
Paid 22-Sep-17 25-May-17
Amount 11.00¢ 22.00¢

Trades for 23-Feb-2018

Time Volume / Share Price
16:53 2 @ 888.60p
16:52 2,452 @ 890.92p
16:52 100 @ 889.54p
16:52 4,000 @ 888.16p
16:52 43 @ 888.57p

HIK Key Personnel

CFO Khalid Nabilsi
CEO Sigurdur Olafsson

Top of Page